<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: liver enzymes</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>NAFLD increases the risk of early atherosclerotic lesions</title>
   	 <description>A study presented today at the International Liver Congress 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk score (FRS) – showed that NAFLD increases the risk of early atherosclerotic lesions independent of established cardiovascular (CV) risk factors.</description>
     <link>http://medicalxpress.com/news/2013-04-nafld-early-atherosclerotic-lesions.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 26 Apr 2013 06:57:50 EST</pubDate>
	 <guid isPermaLink="false">news286175389</guid>
	 
</item>
<item>
     <title>A new treatment option for alcohol dependence: Reduced consumption rather than abstinence</title>
   	 <description>A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.</description>
     <link>http://medicalxpress.com/news/2013-04-treatment-option-alcohol-consumption-abstinence.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 11 Apr 2013 06:02:42 EST</pubDate>
	 <guid isPermaLink="false">news284878955</guid>
	 
</item>
<item>
     <title>Cancers don't sleep: The Myc oncogene can disrupt circadian rhythm</title>
   	 <description>The Myc oncogene can disrupt the 24-hour internal rhythm in cancer cells. Postdoctoral fellow Brian Altman, PhD, and graduate student Annie Hsieh, MD, both from the in the lab of Chi Van Dang, MD, PhD, director of the Abramson Cancer Center, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, present their data in the &quot;Metabolic Pathway Regulation in Cancer&quot; session at the 2013 American Association for Cancer Research meeting, Washington, D.C., April 9, 2013.</description>
     <link>http://medicalxpress.com/news/2013-04-cancers-dont-myc-oncogene-disrupt.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 09 Apr 2013 15:00:03 EST</pubDate>
	 <guid isPermaLink="false">news284730928</guid>
	 
</item>
<item>
     <title>BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test</title>
   	 <description>A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics For All (DFA), a Cambridge, MA nonprofit dedicated to improving the health of people living in the developing world.</description>
     <link>http://medicalxpress.com/news/2012-09-bidmc-diagnostics-low-cost-paper-based-liver.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 19 Sep 2012 14:01:02 EST</pubDate>
	 <guid isPermaLink="false">news267281992</guid>
	 
</item>
<item>
     <title>Four acute mushroom poisonings in two weeks</title>
   	 <description>On September 12, 2011, a Springfield, Virginia man arrived at MedStar Georgetown University Hospital (MGUH) in the early stages of liver failure. The man had mistakenly eaten poisonous mushrooms, handpicked from his yard. He would be the first of four patients in the course of two weeks to seek treatment at MGUH for mushroom (amanitin) poisoning. Their clinical course, management, and outcomes were presented today at Digestive Disease Week (DDW) in San Diego, the largest international gathering of physicians and researchers in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.</description>
     <link>http://medicalxpress.com/news/2012-05-acute-mushroom-poisonings-weeks.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 20 May 2012 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news256713648</guid>
	 
</item>
<item>
     <title>American Heart Association comment: FDA announces safety changes on labeling for some statins</title>
   	 <description>The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).</description>
     <link>http://medicalxpress.com/news/2012-02-american-heart-association-comment-fda.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 29 Feb 2012 09:11:08 EST</pubDate>
	 <guid isPermaLink="false">news249729060</guid>
	 
</item>
<item>
     <title>Gut hormone leads to weight loss in overweight or obese patients</title>
   	 <description>Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical Journal today.</description>
     <link>http://medicalxpress.com/news/2012-01-gut-hormone-weight-loss-overweight.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Tue, 10 Jan 2012 18:54:21 EST</pubDate>
	 <guid isPermaLink="false">news245444054</guid>
	 
</item>
<item>
     <title>Largest ever genetic study of liver function could point the way to new treatments</title>
   	 <description>Researchers have identified a large number of areas in the human genetic code that are involved in regulating the way in which the liver functions, in a new study of over 61,000 people, published today in the journal Nature Genetics.</description>
     <link>http://medicalxpress.com/news/2011-10-largest-genetic-liver-function-treatments.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 16 Oct 2011 13:00:21 EST</pubDate>
	 <guid isPermaLink="false">news237981802</guid>
	 
</item>
<item>
     <title>Coffee drinking improves hepatitis C treatment response</title>
   	 <description>Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non-drinkers.</description>
     <link>http://medicalxpress.com/news/2011-06-coffee-hepatitis-treatment-response.html</link>
	 <category>Addiction</category>
	 <pubDate>Tue, 07 Jun 2011 10:35:05 EST</pubDate>
	 <guid isPermaLink="false">news226661649</guid>
	 
</item>


</channel>
</rss>
